Proteus Digital Health, Inc., Fairview Health Services, and the University of Minnesota Health announced that for the first time cancer patients are using digital oncology medicines to support treatment regimens and improve outcomes. This advancement helps patients complete oral chemotherapy cycles while oncologists gain new insights into their patients’ treatment progress and overall health status. Proteus, Fairview, and the University of Minnesota Health unveiled the care model for digital
Read More
Big Data Cancer
Oncology Analytics Raises $21M to Provide Health Plans With Evidence-Based Analytics for Utilization Management
Oncology Analytics, an Atlanta-based digital health startup that provides health plans, providers and patients with an evidence-based, analytics focused approach to utilization management for oncology, today announced it has raised $21 million in Series B funding. The Series B round was led by Oak HC/FT and was joined by new investor McKesson Ventures along with returning investors Blue Cross Blue Shield Venture Partners and Sandbox Advantage Fund. The startup plans to use the capital to expand
Read More
Precision Health AI Launches Oncology AI Platform Driven by EMR Dataset
Precision Health AI, a healthcare technology company focused on the application of artificial intelligence to cancer care, today announced the launch of the Eureka Health Oncology AI Platform. The 60+ set of pre-trained AI solution modules will utilize Precision Health AI’s proprietary data to predict a patient’s cancer stage, treatment journey, flow through the healthcare system and survival rate.Driving the new Eureka Health Oncology AI platform is Precision Health AI’s deep, longitudinal
Read More
Biotech Startup Lantern Pharma Raises $3.7M to Accelerate Cancer Drug Approval Process
Clinical-stage biotech company Lantern Pharma Inc. has raised $3.7 million in Series A funding led by BIOS Partners, GPG Ventures and other private investors. Using big data and artificial intelligence, Lantern Pharma focused exclusively on accelerating the cancer drug approval process.The startup plans to utilize the funding to continue development of its two lead drug candidates and further the advancement of its big data and Artificial Intelligence (AI) platform. Lantern’s strategy focuses on
Read More
GRAIL Lands $900M for Early Cancer Detection
GRAIL, Inc., a life sciences company whose mission is to detect cancer early when it can be cured, today announced it has raised $900 million in Series B funding led by ARCH Venture Partners with participation from Johnson & Johnson Innovation, Amazon, Bristol-Myers Squibb, Celgene, McKesson Ventures, Merck (known as MSD outside the United States and Canada), Tencent Holdings Limited and Varian Medical Systems, Inc. GRAIL intends to close the remainder of the Series B investment prior to the
Read More
IBM Watson, Illumina Partner to Simplify Genomic Data Interpretation
IBM Watson Health and Illumina are teaming up to standardize and simplify genomic data interpretation by integrating Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process. Genome sequencing has increased in recent years following two decades of research demonstrating the promise of precision medicine. However, access to these advances has been limited by the significant time and expense required to interpret the genomic data.By integrating Watson for Genomics
Read More
Specimatch Launches Clinical Trial Monitoring Platform for Cancer Patients
Specimatch, a continual clinical trial monitoring service, has unveiled the web-based software service for cancer patients and oncologists. On Specimatch.com, users can easily and intuitively connect to clinical trials personally matched to the patient’s genetic and clinical profiles.Founded in 2016 by Dr. Ken Dixon, founder/surgical oncologist of Surgical Oncologists of Northeast Georgia, Specimatch.com’s interface was created to let both clinicians and patients take part in the management of
Read More
FDA, Flatiron Health Team Up for Cancer Research Initiative
Flatiron Health and the FDA have teamed up on a new research collaboration agreement to determine how real-world evidence derived from de-identified, HIPAA-compliant patient data captured outside of clinical trials can provide new insights into the safety and effectiveness of emerging anti-cancer therapies such as immunotherapeutic agents.Research Initiative DetailsAs part of this research initiative, Flatiron Health and the FDA are collaborating on a project to investigate the use of
Read More
Big Data Cancer Platform COTA Secures $3.7M in Funding from Insurer
Big data cancer platform COTA closes $3.7M of planned $7M Series A funding round to make value-based cancer care delivery and reimbursement a reality.
The promise of value-based care and big data insights in healthcare are undeniable. But few have found a way to integrate it in a real-life setting and obtain the consensus of payers, providers, patients, technology partners etc. COTA, which today closed $3.7M in Series A funding from Horizon Healthcare Services, Inc. , is changing that status
Read More
